Latest News and Press Releases
Want to stay updated on the latest news?
-
CERTARA APPOINTS DR. ADRIAN MCKEMEY AS PRESIDENT OF DRUG DEVELOPMENT SOLUTIONS
-
NEWARK, Del, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The global peptone market is projected to grow steadily, with sales estimated at USD 846.4 million in 2024 and expected to reach USD 1,299.0 million by...
-
Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.
-
Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.
-
Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.
-
Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.
-
Certara has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.
-
Certara today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers.
-
NEWARK, Del, April 23, 2024 (GLOBE NEWSWIRE) -- The mammalian cell fermentation technology market is estimated to be worth US$ 45.9 billion in 2024 and is projected to be valued at US$ 68 billion by...
-
Combined Certara-Applied Biomath organization establishes the life sciences industry’s largest quantitative systems pharmacology center.